Use of tympanostomy tubes in Otitis media

W. L. Meyerhoff

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Tympanostomy tubes (TT) are frequently employed as treatment for otitis media (OM) although there is little clinical or experimental evidence of their efficacy. Potential detriments of TT include cost, risk of inhalation anesthesia, intraoperative complications, and tympanic membrane (TM) damage. Potential benefits include elimination of the conductive hearing loss (CHL), reduction in the occurrence of acute purulent OM, and avoidance of sequelae. The cost/benefit ratio of TT has never been accurately determined and morbid complications of inhalation anesthesia and the surgical procedure appear to be rare. There is evidence that TT significantly reduce the CHL of OM as well as reduce the incidence of recurrent acute purulent OM and help avoid sequelae. It is therefore determined that the risk of TT insertion for middle ear effusion (occasional TM changes) can be justified, in properly selected patients, by the benefits (immediate improvement in hearing and reduction in the incidence of recurrent acute purulent OM).

Original languageEnglish (US)
Pages (from-to)537-542
Number of pages6
JournalAnnals of Otology, Rhinology & Laryngology
Issue number6
StatePublished - Nov 1981

ASJC Scopus subject areas

  • Otorhinolaryngology


Dive into the research topics of 'Use of tympanostomy tubes in Otitis media'. Together they form a unique fingerprint.

Cite this